The latest immunotherapy news and developments
A personalised tumour cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an…
Cancer patients generally have a higher thrombotic risk than the population at large. This risk…
Diffuse gliomas are usually incurable brain tumours that spread in the brain and are difficult…
Scientists have genetically engineered immune cells, called myeloid cells, to precisely deliver an anticancer signal…
Researchers found for the first time that immunotherapy is significantly less effective in liver cancer…
By targeting an enzyme that plays a key role in head and neck cancer cells,…
Some melanoma patients respond very well to immunotherapy, experiencing profound and durable tumour regression. A…
Immunotherapy, which recruits the body’s own immune system to attack cancer, has given many cancer…
Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than…
Cancer immunotherapy may get a boost from an unexpected direction: bacteria residing within tumour cells.…